OxSyBio Company
OxSyBio is developing 3D printing techniques to produce a range of tissue-like & functional tissues for medical research.
Founded Date:
2014-01-01
Last Funding Type:
Series A
Headquarters:
London, England, United Kingdom
Technology:
Organ Engineering
Employee Number:
1-10
Industry:
3D Printing, 3D Technology, Biotechnology, Medical, Regenerative medicine
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018
Funding Status:
Early Stage Venture
Total Funding:
15584161